根据疾病的严重程度,查尔科-玛丽-牙病1A型的步态模式
Jihyun Park1, So Young Joo2, Byung-Ok Choi3
1Department of Rehabilitation Medicine, Hallym University Dongtan Sacred Heart Hospital, College of Medicine, Hallym University, Hwaseong 18450, Republic of Korea.
Journal of personalized medicine
|October 27, 2023
概括
查洛特玛丽牙病1A型 (CMT1A) 患者的步行模式与健康个体有显著差异. CMT1A患者表现出明显的步态特征,这些特征随疾病严重程度而变化,影响治疗策略.
科学领域:
- 神经学 神经学
- 生物力学 生物力学
- 整形外科 整形外科 整形外科
背景情况:
- 查洛-玛丽-牙病1A型 (CMT1A) 是一种渐进的遗传性神经病变.
- 步行障碍是CMT1A患者的常见和衰弱症状.
- 了解步态变化对于管理CMT1A进展和患者生活质量至关重要.
研究的目的:
- 调查和描述CMT1A患者的步态模式.
- 为了比较轻度和中度CMT1A严重程度群体和健康对照群体之间的步行特征.
- 为了确定CMT1A.中随疾病严重程度而变化的步态参数.
主要方法:
- 对22名CMT1A患者 (轻度和中度组) 和22名健康对照进行了三维步态分析.
- 在赤脚条件下收集了时空,运动和运动步态数据.
- 使用统计分析来比较不同组的步态参数.
主要成果:
- 与对照人群相比,CMT1A患者在关节绑架,关节延伸,膝盖曲时刻,脚背曲,脚脚下曲和脚旋转方面表现出显著差异 (p <0.05).
- 与对照组和轻度CMT1A组相比,中度CMT1A组在摆动时表现出更大的最大部曲和减少初始接触背部曲.
- 在CMT1A患者的步行模式是不同的,并显示基于疾病严重性的可观察变化.
结论:
- 步行分析揭示了CMT1A患者的特定生物力学变化.
- 疾病的严重程度显著影响CMT1A.中的步态特征.
- 这些发现为开发针对CMT1A患者的有针对性的治疗干预提供了宝贵的见解.
相关概念视频
01:18Actin Treadmilling
Actin filaments undergo polymerization and depolymerization from either end. The polymerization and depolymerization rates depend on the cytosolic concentration of free G-actins. The polymerization rate is generally higher at the plus or barbed end, while the depolymerization rate is higher at the minus or pointed end. At a steady state, critical concentration describes the concentration of free G-actin monomers at which the polymerization rate at the plus end is equal to that of the...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...